Security key
682310875
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY)
CUSIP: 682310875
Q4 2021 13F Holders as of 31 Dec 2021
- Type / Class
- Equity / Common Stock, no par value
- Shares outstanding
- 109,272,143
- Total 13F shares
- 1,187,087
- Share change
- +217,746
- Total reported value
- $1,652,710
- Price per share
- $1.40
- Number of holders
- 34
- Value change
- +$287,570
- Number of buys
- 16
- Number of sells
- 8
Report period
Q4 2021
Institutions
34
Top holders
10
ONCY full security history
Newer quarter: Q1 2022
Previous quarter: Q3 2021
ONCOLYTICS BIOTECH INC SEC filings
ONCOLYTICS BIOTECH INC company facts
Broader feeds
Reporting periods
Holder history for CUSIP 682310875
Recent filing periods:
Top shareholders of ONCY - ONCOLYTICS BIOTECH INC - Common Stock, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.19%
|
209,900
|
$439,000 | — | 30 Sep 2021 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.16%
|
170,576
|
$357,000 | — | 30 Sep 2021 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.13%
|
147,473
|
$900,000 | — | 30 Sep 2021 | |
| MORGAN STANLEY |
13F
|
Company |
0.08%
|
83,152
|
$174,000 | — | 30 Sep 2021 | |
| CIBC WORLD MARKET INC. |
13F
|
Company |
0.06%
|
61,654
|
$129,000 | — | 30 Sep 2021 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.04%
|
40,555
|
$85,000 | — | 30 Sep 2021 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
39,200
|
$82,000 | — | 30 Sep 2021 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
34,659
|
$72,000 | — | 30 Sep 2021 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.03%
|
33,485
|
$70,000 | — | 30 Sep 2021 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
27,213
|
$56,000 | — | 30 Sep 2021 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
26,778
|
$56,000 | — | 30 Sep 2021 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
20,489
|
$43,000 | — | 30 Sep 2021 | |
| BRAVE ASSET MANAGEMENT INC |
13F
|
Company |
0.02%
|
20,000
|
$42,000 | — | 30 Sep 2021 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
16,988
|
$36,000 | — | 30 Sep 2021 | |
| COMERICA BANK |
13F
|
Company |
0.01%
|
15,526
|
$35,000 | — | 30 Sep 2021 | |
| Newman Dignan & Sheerar, Inc. |
13F
|
Company |
0.01%
|
12,915
|
$27,000 | — | 30 Sep 2021 | |
| Cantonale Vaudoise Banque |
13F
|
Individual |
0.01%
|
11,268
|
$24,000 | — | 30 Sep 2021 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.01%
|
10,531
|
$22,000 | — | 30 Sep 2021 | |
| CHIRON CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
10,200
|
$21,000 | — | 30 Sep 2021 | |
| Crescent Grove Advisors, LLC |
13F
|
Company |
0.01%
|
10,000
|
$21,000 | — | 30 Sep 2021 | |
| NEXT Financial Group, Inc |
13F
|
Company |
0.01%
|
8,550
|
$18,000 | — | 30 Sep 2021 | |
| Cedar Mountain Advisors, LLC |
13F
|
Company |
0.01%
|
5,651
|
$12,000 | — | 30 Sep 2021 | |
| Rockefeller Capital Management L.P. |
13F
|
Company |
0.01%
|
5,540
|
$11,000 | — | 30 Sep 2021 | |
| Disciplined Investments, LLC |
13F
|
Company |
0%
|
5,189
|
$11,000 | — | 30 Sep 2021 | |
| IFP Advisors, Inc |
13F
|
Company |
0%
|
5,000
|
$10,000 | — | 30 Sep 2021 | |
| Zions Bancorporation, N.A. |
13F
|
Company |
0%
|
5,000
|
$10,000 | — | 30 Sep 2021 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0%
|
3,407
|
$6,946 | — | 30 Sep 2021 | |
| OSAIC HOLDINGS, INC. |
13F
|
Company |
0%
|
2,962
|
$6,000 | — | 30 Sep 2021 | |
| HARBOUR INVESTMENTS, INC. |
13F
|
Company |
0%
|
2,330
|
$5,000 | — | 30 Sep 2021 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
1,500
|
$3,000 | — | 30 Sep 2021 | |
| TORONTO DOMINION BANK |
13F
|
Company |
0%
|
1,306
|
$3,000 | — | 30 Sep 2021 | |
| FIFTH THIRD BANCORP |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 30 Sep 2021 | |
| SITTNER & NELSON, LLC |
13F
|
Company |
0%
|
1,000
|
$2,000 | — | 30 Sep 2021 |
Institutional Holders of ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) as of Q4 2021
As of 31 Dec 2021,
ONCOLYTICS BIOTECH INC - Common Stock, no par value (ONCY) was held by
34 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,187,087 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC, Advisor Resource Council, CITADEL ADVISORS LLC, MORGAN STANLEY, CIBC World Markets Inc., TWO SIGMA ADVISERS, LP, ROYAL BANK OF CANADA, Long Focus Capital Management, LLC, and JPMORGAN CHASE & CO.
This page lists
34
institutional shareholders reporting positions in this security
for the Q4 2021 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2021 vs Q3 2021 Across Filers
Q3 2021 holders
32
Q4 2021 holders
34
Holder diff
2
| Investor | Q3 2021 Shares | Q4 2021 Shares | Share Diff | Share Chg % | Q3 2021 Value $ | Q4 2021 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.